Market fit MOgene specializes in genomic services for agriculture, pharmaceutical, and industrial biotech sectors, presenting cross-industry opportunities for contract research, external collaborations, and custom sequencing projects.

Growth potential With a lean team and revenue in the lower mid-range, MOgene may be open to partnerships that scale services, expand capabilities, or co-develop research programs without high onboarding risk.

Key capabilities Their strengths include PacBio Sequel, Illumina sequencing, microarrays, multiplex assays, nucleic acid extraction, qPCR, clinical assays, and full bioinformatics, enabling upsell of end-to-end genomic workflows and data analysis services.

Industry credibility A track record of collaborations and over 100 publications signals reliability and academic/government appeal, making MOgene a strong candidate for grant-backed or consortium-based projects.

Strategic partnerships Small to mid-sized partner networks, combined with an established service reputation, suggest opportunities for white-label collaborations, joint ventures, or pilot studies with risk-sharing models.